Satellite Bio
Tuesday, February 27, 2024
Uris
Metabolic Diseases
Satellite Bio is a well-funded regenerative medicine company with cutting-edge hepatocyte technologies designed to tackle a broad range of liver diseases. Our platform encompasses a proprietary primary hepatocyte expansion technology that allows the dosing of over 1000 patients from a single donor liver, decoupling the need for a single donor organ per patient. Additionally, we specialize in stabilizing hepatocytes in heterocellular aggregates, enabling cryopreservation for long-term stability and shipment, as well as significantly improved in vivo engraftment and durability. Our expertise also extends to the generation of engineered hepatocytes optimized for the endogenous expression of therapeutic proteins. This presentation will offer an overview of Satellite Bio’s technology and therapeutic vision
State
MA
Country
United States
Website
http://satellite.bio
CEO/Top Company Official
Laura Lande-Diner, President&CBO and Tom Lowery, President&CTO
Lead Product in Development
HepSEED
Development Phase of Primary Product
Pre-Clinical
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}